NESS ZIONA, Israel, March 18, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, clinical, late stage biopharmaceutical company, announced today that it has received complementary funding ...
To promote interoperability between messaging systems that support different sets of MAPI features, MAPI provides the Transport Neutral Encapsulation Format (TNEF) as a standard way to transfer data.
Plant will enable Mapi to supply the initial commercial needs of GA Depot NESS ZIONA, Israel, March 18, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, clinical, late stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback